Filing Details
- Accession Number:
- 0001209191-20-013016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-26 16:29:10
- Reporting Period:
- 2020-02-24
- Accepted Time:
- 2020-02-26 16:29:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Transaction Summary
| Sold: | 3,028 shares | Avg. Price: $233.41 | Total Value: $706,775.76 |
| Number of Shares After Transactions: | 28,902 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-24 | 2,416 | $239.23 | 31,930 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-02-25 | 734 | $229.72 | 31,196 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 400 | $230.77 | 30,796 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 400 | $232.51 | 30,396 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 574 | $234.52 | 29,822 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 280 | $235.53 | 29,542 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 160 | $236.80 | 29,382 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-25 | 480 | $238.33 | 28,902 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $229.72 (range $229.23 to $230.14).
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $230.77 (range $230.29 to $231.27).
- Open market sales reported on this line occurred at a weighted average price of $232.51 (range $232.33 to $233.04).
- Open market sales reported on this line occurred at a weighted average price of $234.52 (range $234.22 to $234.82).
- Open market sales reported on this line occurred at a weighted average price of $235.53 (range $235.43 to $235.72).
- Open market sales reported on this line occurred at a weighted average price of $238.33 (range $238.16 to $238.54).
Billionaire Hedge Funds
